RIVASTIGMINA TEVAGEN 13,3 MG/24 H PARCHES TRANSDERMICOS EFG

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: bc47e2156bf63a03
Drug Cima Aemps Name: RIVASTIGMINA TEVAGEN 13,3 MG/24 H PARCHES TRANSDERMICOS EFG
Register Number: 86432
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2022-04-05
Dosage Form: PARCHE TRANSDÉRMICO
Dose: 13,3 mg/24 h
Route Of Administration: VÍA TRANSDÉRMICA
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

RIVASTIGMINA

19,2 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 5, 2022

Approval ID

bc47e2156bf63a03

Type

Standard